Indications and uses
Helps prevent sunburn.
L'BEL RENOVANCE JOUR Daytime Face Cream SPF 15 All Skin Types
- Manufacturer
- VENTURA INTERNATIONAL LTD. | MF PRODUCTIONS
- Effective date
- 2012-03-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:20
Label at a glance#
ProductLBEL RENOVANCE JOUR Daytime Face SPF 15 All Skin Types
Active ingredientOCTINOXATE, OCTOCRYLENE, OXYBENZONE
Label structure10 sections
Dosage and administration
Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 years Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor.
Label contents#
Full prescribing information#
Active Ingredients
OCTINOXATE (7.5%)
OCTOCRYLENE (5.0%)
OXYBENZONE (3.0%)
Uses
- Helps prevent sunburn.
Warnings
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
- For external use only.
Do not use
on damaged or broken skin.
When using this product
keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
rash occurs.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 years
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor.
Other Information
- Protect the product in this container from excessive heat and direct sun.
Inactive Ingredients
Aqua (water), cyclohexasiloxane, soy protein phthalate, c12-15 alkyl benzoate, glycerin, pisum sativum extract (pisum sativum (pea) extract), caprylic/capric triglyceride, cyclopentasiloxane, cetyl alcohol, cetearyl alcohol, isononyl isononanoate, isopropyl myristate, sorbitan stearate, mannitol , glyceryl stearate, potassium cetyl phosphate, dimethicone, propylene glycol, peg-75 stearate, sodium pca, methylparaben, dimethicone crosspolymer, dimethicone/vinyl dimethicone crosspolymer, phenoxyethanol, acrylates/c10-30 alkyl acrylate crosspolymer, triethanolamine, ceteareth-20, panthenol, propylparaben, dimethiconol, ceteth-20, steareth-20, chlorphenesin, ci 77891 (titanium dioxide), parfum (fragrance), teprenone, butylene glycol, cyclodextrin, tetrasodium edta, peg-40 hydrogenated castor oil, polysorbate 80, ppg-26-buteth-26, serine, urea, hydrolyzed algin, hedera helix extract (hedera helix (ivy) leaf/stem extract), faex extract (yeast extract), magnesium pca, chlorella vulgaris extract, retinyl palmitate, maris aqua (sea water), tocopheryl acetate, algin, zinc pca, bioflavonoids, allantoin, ascorbyl palmitate, saccharomyces/magnesium ferment, acacia senegal gum, disodium succinate, saccharomyces/iron ferment, manganese pca, saccharomyces/copper ferment, saccharomyces/calcium ferment, saccharomyces/silicon ferment, saccharomyces/zinc ferment.
Purpose
Sunscreen
EXPERT ROUTINE L'BEL
L'Bel presents Expert Routine, a skin care program with two steps that work together for enhanced results:
1. Cleanse the skin according to its needs.
2. Nourish according to the age.
RENOVANCE JOUR
intensive, refining, fortifying and renewing daytime face cream SPF 15
After the age of 50, your skin reflects certain changes brought about by the passage of time: increased dullness and loss of density and luminosity
The alternative facial cosmetic treatment
Renovance Jour with Solar Protection Factor (SPF) 15, combines the innovations and scientific advances in cosmetics with the mineral supplements that mature skin needs. An effective synergy for a unique cosmetic treatment that deeply moisturizes the skin and helps fortify and renew the look of your face.
An effective cosmetic treatment that supports the actions of its ingredients:
WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
1. Cleanse the skin according to its needs.
2. Nourish according to the age.
RENOVANCE JOUR
intensive, refining, fortifying and renewing daytime face cream SPF 15
After the age of 50, your skin reflects certain changes brought about by the passage of time: increased dullness and loss of density and luminosity
The alternative facial cosmetic treatment
Renovance Jour with Solar Protection Factor (SPF) 15, combines the innovations and scientific advances in cosmetics with the mineral supplements that mature skin needs. An effective synergy for a unique cosmetic treatment that deeply moisturizes the skin and helps fortify and renew the look of your face.
An effective cosmetic treatment that supports the actions of its ingredients:
- Renovage Complex: helps improve the skin’s appearance of firmness, elasticity and tone that has been lost over time.
- Vitaminerale Boost: complex, rich in vitamins and minerals, which give the skin a fortifying and energizing effect.
- Hydra Chronological System: innovative technology, patented in France, that gives skin progressive, long-lasting and focused hydration where it needs it most. Its formula also contains soy proteins that give the skin an immediate lift appearance.
WARNINGS: Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 hours.
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor.
- Protect the product in this container from excessive heat and direct sun.
- HYPOALLERGENIC PRODUCT
- CLINICALLY TESTED
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
L'BEL RENOVANCE JOUR intensive refining, fortifying and renewing daytime face cream SPF 15 all skin types 50g e (1.7 oz.) Renovance Jour with Solar Protection Factor (SPF) 15, combines the innovations and scientific advances in cosmetics with the mineral supplements that mature skin needs. An effective synergy for unique cosmetic treatment that deeply moisturizes the skin and helps fortify and renew the look of your face.
L'BEL RENOVANCE JOUR Daytime Face Cream SPF 15 All Skin Types
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43455-0004-0 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c8e4-f6ea-e053-dbdaa90aa703 | L'BEL RENOVANCE JOUR Daytime Face Cream SPF 15 All Skin Types |
| 43455-0004-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c8e4-f6ea-e053-dbdaa90aa703 | L'BEL RENOVANCE JOUR Daytime Face Cream SPF 15 All Skin Types |
| 43455-0004-2 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c8e4-f6ea-e053-dbdaa90aa703 | L'BEL RENOVANCE JOUR Daytime Face Cream SPF 15 All Skin Types |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43455-0004-0 | LBEL RENOVANCE JOUR Daytime Face SPF 15 All Skin Types | 1 g in 1 POUCH | CREAM | 1 | 1 | |
| 43455-0004-1 | LBEL RENOVANCE JOUR Daytime Face SPF 15 All Skin Types | 5 g in 1 JAR | CREAM | 5 | 1 | |
| 43455-0004-2 | LBEL RENOVANCE JOUR Daytime Face SPF 15 All Skin Types | 50 g in 1 JAR | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43455-0004 | LBEL RENOVANCE JOUR DAYTIME FACE SPF 15 ALL SKIN TYPES (OCTINOXATE, OCTOCRYLENE, OXYBENZONE) CREAM [VENTURA INTERNATIONAL LTD.] | 1 | Legacy NDC, 3 package rows | 20120404_c916f7fc-9bd9-4ec4-991e-cc8d9703ee55.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ASCORBYL PALMITATE | INACTIVE INGREDIENT | QN83US2B0N | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CARBOMER INTERPOLYMER TYPE A (55000 MPA.S) | INACTIVE INGREDIENT | 59TL3WG5CO | 1 | |
| CETETH-20 | INACTIVE INGREDIENT | I835H2IHHX | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHLORELLA VULGARIS | INACTIVE INGREDIENT | RYQ4R60M02 | 1 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| HEDERA HELIX LEAF | INACTIVE INGREDIENT | ZP9XFG71A7 | 1 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 1 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PEA | INACTIVE INGREDIENT | W4X7H8GYFM | 1 | |
| PEG-75 STEARATE | INACTIVE INGREDIENT | OT38R0N74H | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYOXYL 20 CETOSTEARYL ETHER | INACTIVE INGREDIENT | YRC528SWUY | 1 | |
| POLYOXYL 40 HYDROGENATED CASTOR OIL | INACTIVE INGREDIENT | 7YC686GQ8F | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 1 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| SODIUM SUCCINATE ANHYDROUS | INACTIVE INGREDIENT | V8ZGC8ISR3 | 1 | |
| SORBITAN MONOSTEARATE | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| STEARETH-20 | INACTIVE INGREDIENT | L0Q8IK9E08 | 1 | |
| TEPRENONE | INACTIVE INGREDIENT | S8S8451A4O | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 1 | |
| VITAMIN A PALMITATE | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| YEAST | INACTIVE INGREDIENT | 3NY3SM6B8U | 1 | |
| ZINC PIDOLATE | INACTIVE INGREDIENT | C32PQ86DH4 | 1 |
Products#
Every source-derived product name is available through these pages.
- LBEL RENOVANCE JOUR Daytime Face SPF 15 All Skin Types
- OCTINOXATE, OCTOCRYLENE, OXYBENZONE
- OCTINOXATE
- OCTOCRYLENE
- OXYBENZONE
- WATER
- CYCLOMETHICONE 6
- ALKYL (C12-15) BENZOATE
- GLYCERIN
- PEA
- MEDIUM-CHAIN TRIGLYCERIDES
- CYCLOMETHICONE 5
- CETYL ALCOHOL
- CETOSTEARYL ALCOHOL
- ISONONYL ISONONANOATE
- ISOPROPYL MYRISTATE
- SORBITAN MONOSTEARATE
- MANNITOL
- GLYCERYL MONOSTEARATE
- POTASSIUM CETYL PHOSPHATE
- DIMETHICONE
- PROPYLENE GLYCOL
- PEG-75 STEARATE
- SODIUM PYRROLIDONE CARBOXYLATE
- METHYLPARABEN
- PHENOXYETHANOL
- CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)
- TROLAMINE
- POLYOXYL 20 CETOSTEARYL ETHER
- PANTHENOL
- PROPYLPARABEN
- CETETH-20
- STEARETH-20
- CHLORPHENESIN
- TITANIUM DIOXIDE
- TEPRENONE
- BUTYLENE GLYCOL
- EDETATE SODIUM
- POLYOXYL 40 HYDROGENATED CASTOR OIL
- POLYSORBATE 80
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43455-0004 | 43455-0004-0, 43455-0004-1, 43455-0004-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| STEARETH-20 | STEARETH-20 | L0Q8IK9E08 | CREAM / TOPICAL | 4.15 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | FILM / BUCCAL | 0.22 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRA-ARTICULAR | 4 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / AURICULAR (OTIC) | 0.2 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 5 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL / TOPICAL | 9.3 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.05 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | OINTMENT / TOPICAL | 0.1 %w/w | ||
| POLYOXYL 40 HYDROGENATED CASTOR OIL | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION/ DROPS / OPHTHALMIC | 0.53 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER, FOR SUSPENSION / ORAL | 297 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET / BUCCAL | 360 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / ORAL | 1 mg/1ml | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / OPHTHALMIC | 4.7 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SPRAY / NASAL | 41.5 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER / ORAL | 4352 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRASYNOVIAL | 0.2 %w/v | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | LOTION / TOPICAL | 89 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SOLUTION / INTRAMUSCULAR | 5 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | POWDER / ORAL | 66 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | 180 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a1740037-6944-4a4e-a6ef-1b9744c62980 | c916f7fc-9bd9-4ec4-991e-cc8d9703ee55 | 2012-03-29 | Warnings | a1740037-6944-4a4e-a6ef-1b9744c62980 c916f7fc-9bd9-4ec4-991e-cc8d9703ee55 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.